Nom du produit:7-chloro-5-(pentan-3-yl)pyrazolo[1,5-a]pyrimidine
IUPAC Name:7-chloro-5-(pentan-3-yl)pyrazolo[1,5-a]pyrimidine
- CAS：2416875-06-2
- Formule moléculaire：C11H14ClN3
- Pureté：95%+
- Numéro de catalogue：CM1075274
- Poids moléculaire：223.7
| Unité d'emballage |
Stock disponible |
Prix($) |
Quantité |
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:2416875-06-2
- Formule moléculaire:C11H14ClN3
- Point de fusion:-
- Code SMILES:CCC(CC)C1=NC2=CC=NN2C(Cl)=C1
- Densité:
- Numéro de catalogue:CM1075274
- Poids moléculaire:223.7
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- Pyrazolopyrimidines
- Pyrazolopyrimidine scaffolds are one of the most important heterocyclic compounds in drug discovery. This scaffold has various biological activities, among which anticancer is an important one.
Column Infos
- KB-0742
- Kronos Bio announces the first patient dosed in an expansion cohort with KB-0742 at a dose of 80mg given on a four-days-on, three-days-off schedule. This expansion cohort is enrolling platinum-resistant patients with high-grade serous ovarian cancer (HGSOC). Many cancers exhibit transcriptional deregulation, often characterized by gene amplifications of MYC family oncogene. Targeting the transcription elongation cofactor, cyclin-dependent kinase 9 (CDK9) has emerged as a therapeutic strategy to disrupt MYC oncogenic activity.
KB-0742 is an oral highly selective CDK9 inhibitor designed for the treatment of patients with MYC-amplified and other transcriptionally addicted relapsed or refractory solid tumors, including ovarian, lung, and triple-negative breast cancers.
Recherche 
+86 21 5895 0110 
